SPHRY - Starpharma Holdings Limited

Other OTC - Other OTC Delayed Price. Currency in USD
8.90
+0.12 (+1.42%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close8.77
Open8.90
Bid0.00 x 0
Ask0.00 x 0
Day's Range8.90 - 8.90
52 Week Range6.61 - 11.87
Volume300
Avg. Volume1,824
Market Cap339.644M
Beta (3Y Monthly)1.89
PE Ratio (TTM)N/A
EPS (TTM)-0.22
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Should You Worry About Starpharma Holdings Limited's (ASX:SPL) CEO Pay Cheque?
    Simply Wall St.last month

    Should You Worry About Starpharma Holdings Limited's (ASX:SPL) CEO Pay Cheque?

    In 2006 Jackie Fairley was appointed CEO of Starpharma Holdings Limited (ASX:SPL). This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Next, we'll consider...

  • Who Has Been Buying Starpharma Holdings Limited (ASX:SPL) Shares?
    Simply Wall St.4 months ago

    Who Has Been Buying Starpharma Holdings Limited (ASX:SPL) Shares?

    We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. Unfortunately, there are also plenty of examples of share prices Read More...

  • Business Wire5 months ago

    VivaGel® Condom Receives Final Regulatory Approval in Japan

    Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that the VivaGel® condom has received final regulatory approval and is now able to be marketed in Japan, following the completion of the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) review of the product's medical device classification and associated data. This final approval follows on from the previously granted regulatory certification, which was attained for the VivaGel® condom. Starpharma has worked closely with its commercial partner for Japan, Okamoto Industries (Okamoto), throughout the regulatory process.

  • Simply Wall St.6 months ago

    Could The Starpharma Holdings Limited (ASX:SPL) Ownership Structure Tell Us Something Useful?

    A look at the shareholders of Starpharma Holdings Limited (ASX:SPL) can tell us which group is most powerful. Institutions often own shares in more established companies, while it’s not unusual Read More...

  • Business Wire11 months ago

    Starpharma Licenses VivaGel® BV to Mundipharma for Europe

    Starpharma (ASX: SPL, OTCQX: SPHRY) and Mundipharma today announced they have signed a licence agreement for the sales and marketing rights to VivaGel® BV for 43 countries in Europe, Russia, the Commonwealth of Independent States (CIS) and the balance of countries in Latin America.